Company: LIDRW
Filing Date: 2025-02-25
Form Type: S-1/A
Source: 0000947871-25-000219
Chunk: 22

Company: AEye, Inc.
Filing Date: 2025-02-25
Form: S-1/A
Chunk 22
---
 of shares of Common Stock beneficially owned by the Selling Stockholders, based on their respective ownership
of shares of Common Stock, notes and warrants as of February 18, 2025, assuming conversion or exercise of the Securities held by each
such Selling Stockholder on that date but taking account of any limitations on conversion and exercise set forth therein.

The fourth column lists the shares of Common
Stock being offered by this prospectus by the Selling Stockholders and does not take into account any limitations on conversion or exercise
of the Securities as set forth therein.

In accordance with the terms of the Registration
Rights Agreement with the holders of the Convertible Note and Warrant, this prospectus generally covers the resale of 150% of the sum
of (i) the maximum number of shares of Common Stock issued or issuable pursuant to the Convertible Note, including payment of interest
on the notes through January 3, 2026, and (ii) the maximum number of shares of Common Stock issued or issuable upon exercise of the Warrant,
determined as if the outstanding Convertible Note (including interest on the notes through January 3, 2026) and the Warrant were converted
or exercised (as the case may be) in full (without regard to any limitations on conversion or exercise contained therein solely for the
purpose of such calculation) at an alternate conversion price or exercise price (as the case may be) calculated as of the trading day
immediately preceding the date this registration statement was initially filed with the SEC. Because the conversion price and alternate
conversion price of the Securities may be adjusted, the number of shares that will actually be issued may be more or less than the number
of shares being offered by this prospectus. The fifth column assumes the sale of all of the shares offered by the Selling Stockholders
pursuant to this prospectus.

Under the terms of the Convertible Note
and the Warrant, a selling stockholder may not convert the Convertible Note or exercise the Warrant to the extent (but only to the extent)
such selling stockholder or any of its affiliates would beneficially own a number of shares of our Common Stock which would exceed 4.99%
of the outstanding shares of the Company (the “Maximum Percentage”). The number of shares in the second column reflects these
limitations. The Selling Stockholders may sell all, some, or none of their shares in this offering. See “Plan of Distribution.”

| Name                       
 of Selling Stockholders(1